Inactief instrument

Andere talen LENZ Therapeutics, Inc. OTC Markets

Aandelen

LENZ Therapeutics Reports Positive Topline Data From Late-Stage Presbyopia Trials	03/04
LENZ Therapeutics, Inc. Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials	03/04
Lenz Therapeutics' eye disease drugs meet main goal of late-stage study	03/04
LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials	03/04
LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials	02/04
LENZ Therapeutics, Inc.(NasdaqGS:LENZ) added to NASDAQ Composite Index	25/03

Geen resultaten voor deze zoekopdracht